Diversion Control Division, US Department of Justice, Drug Enforcement Administration

RESOURCES > Federal Register Notices > Manufacturers Notice of Registration - 2003 > American Radiolabeled Chemicals, Inc.

Manufacturers Notice of Registration - 2003

[Federal Register: June 17, 2003 (Volume 68, Number 116)] [Notices] [Page 35915] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr17jn03-86]


Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Registration

By Notice dated January 27, 2003, and published in the Federal Register on February 6, 2003, (68 FR 6182), American Radiolabeled Chemicals, Inc., 11624 Bowling Green Drive, St. Louis, Missouri 63146, made application by renewal to the Drug Enforcement Administration to be registered as a bulk manufacturer of the basic classes of controlled substances listed below:

DrugĀ  Schedule
Gamma hydroxybutyric acid (2010) I
Lysergic acid diethylamide (7315) I
Dimethyltryptamine (7435) I
Dihydromorphine (9145) I
Phencyclidine (7471) II
Cocaine (9041) II
Codeine (9050) II
Hydromorphone (9150) II
Oxycodone (9143) II
Thebaine (9333) II
Benzoylecgonine (9180) II
Meperidine (9230) II
Metazocine (9240) II
Morphine (9300) II
Oxymorphone (9652) II

The firm plans to bulk manufacture small quantities of the listed controlled substances as radiolabeled compounds.

No comments or objections have been received. DEA has considered the factors in Title 21, United States Code, Section 823(a) and determined that the registration of American Radiolabeled Chemicals, Inc. to manufacture the listed controlled substances is consistent with the public interest at this time. DEA has investigated American Radiolabeled Chemicals, Inc. to ensure that the company's registration is consistent with the public interest. This investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basic classes of controlled substances listed above is granted.

Dated: June 4, 2003.

Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 03-15194 Filed 6-16-03; 8:45 am]


NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility